MAP3K9 and carcinoma: *Reduces slightly the risk of colorectal cancer*Reduces the risk of colorectal neoplasms in women*Inhibits the growth of carcinoma cells*Decreases the concentration of AKT expression which reduces cellular proliferation*Decreases β-catenin concentration thus enhancing the apoptotic pathway*Regulates miRNA expression through DICER 1 activity*Enhances DNA damage repair*Induces humoral and cell mediated-immune response*Scavenges against oxygen radicals*Quenches reactive oxygen species*Activates MAPK pathway through MAP3K9 interaction*Protects against the formation of colonic aberrant crypt foci